Vitamin C treatment in human leukemia cell lines and primary mice was also shown to induce 5hmC formation, DNA hypomethylation, and TET2/TET3-dependent gene expression involved in BER such as GADD45, PARP, and DNA glycosylase, consequently inhibiting abnormal self-renewal and the progression of cancer cells [125]. The gene discussed is TET2; the disease is cancer.